- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, June 12, 2020
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A piece by Orlando Sentinel highlighted an article published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The article, “New CMS Model Aims to Lower Insulin Costs for Seniors,” noted an announcement by CMS on the Part D Senior Savings Model, allowing Medicare Part D prescription drug plans to offer plan choices that provide a range of insulins to beneficiaries, at a maximum $35 co-pay per 30-day supply throughout the benefit year.
An article by Market Watch cited a piece published on AJMC.com, titled “Low-Income Women Less Likely to Keep Jobs After Breast Cancer Treatment.” The piece spotlighted findings linking women with breast cancer with a 2-fold increased likelihood of returning to work after treatment if their employer makes accommodations for them, but workplace accommodation and job retention were found to be significantly lower for low-income and minority women.
An article by AJMC®’s sister site The Center for Biosimilars® was referenced in a piece by The Pharma Letter, titled “The Purple Book: Transition to a single online source.” The article, “FDA Launches Searchable Database Intended to Replace Static Purple Book Lists,” detailed an announcement by the FDA launching the first phase of its improvement to the Purple Book by moving from a list format to a searchable database, so the public can more easily search biosimilar and biologic products.
Telephone Follow-Up on Medicare Patient Surveys Remains Critical
January 16th 2025Including a telephone component in Medicare Consumer Assessment of Healthcare Providers and Systems survey administration continues to be valuable because telephone responses comprise a substantial portion of responses for several underserved groups.
Read More
Quantifying the Altruism Value for a Rare Pediatric Disease: Duchenne Muscular Dystrophy
January 14th 2025Altruism values for treatments of rare, severe pediatric diseases have not been estimated. This study found the altruism value for a hypothetical new Duchenne muscular dystrophy treatment to be $80 per year.
Read More
Health Equity & Access Weekly Roundup: January 11, 2025
January 11th 2025ACA enrollment rate hits a milestone, though IRA subsidies may not extend beyond 2025; network adequacy standards fail to translate into efficient access to mental health care for Medicaid enrollees; research examines racial disparities in postpartum hypertension and vaccine uptake.
Read More
